irritable bowel syndrome

in review 3 min read Updated 2026-10-28
irritable bowel syndrome

A positive diagnosis (Rome IV), not a diagnosis of exclusion: recurrent abdominal pain ≥1 day/week for 3 months linked to defecation or a change in stool frequency or form. Test minimally: coeliac serology; no routine colonoscopy under 50 without alarm features; new symptoms at ≥50 → colonoscopy. Treat by subtype after explanation and reassurance: low-FODMAP diet, psyllium, peppermint oil, antispasmodics, low-dose TCA (strongest evidence for pain), linaclotide for IBS-C. CAG 2019 is the Canadian reference; ACG and AGA differ on several drugs.

diagnosis

Rome IV: recurrent abdominal pain on average ≥1 day/week in the last 3 months, with ≥2 of: related to defecation · change in stool frequency · change in stool form. Onset ≥6 months before diagnosis.

Subtype by stool form on bad days (Bristol): IBS-C, IBS-D, IBS-M.

what to test (CAG 2019)

testrecommendation
coeliac serologyyes (CAG: all IBS; ACG: IBS with diarrhoea)
CRP, calprotectinCAG against routinely; ACG suggests both in IBS-D without alarm features to exclude IBD
colonoscopy, <50 without alarm featuresno (CAG; ACG: <45)
colonoscopy, <50 with alarm featuresnot routinely — individualise
new symptoms at ≥50colonoscopy
food allergy tests, lactose or glucose breath testsno

Alarm features : age ≥50 at onset, rectal bleeding, nocturnal symptoms, weight loss, iron deficiency anaemia, family history of CRC, IBD or coeliac, palpable mass → investigate (chronic diarrhoea).

treatment

Explain the diagnosis (gut–brain interaction, visceral hypersensitivity) and that it doesn’t progress to serious disease. Then target the dominant symptom.

all subtypes

therapyCAG 2019note
low-FODMAP dietsuggestrestrict 2–6 weeks → reintroduce → personalise; dietitian-led
psyllium (soluble fibre)recommendavoid wheat bran (insoluble — worsens bloating)
gluten-free dietagainst
peppermint oilsuggest
antispasmodics (dicyclomine, hyoscine, pinaverium)suggestACG recommends against
probioticssuggestACG suggests against
low-dose TCA (amitriptyline from 10 mg qhs, titrate)recommendbest evidence for pain; constipating → good for IBS-D
SSRIsuggest
CBT, gut-directed hypnotherapysuggest

IBS-D

  • Eluxadoline: suggested.
  • Rifaximin: CAG no recommendation; ACG recommends.
  • Continuous loperamide: CAG against (helps stool frequency, not pain or global symptoms) — fine as needed.
  • Bile acid sequestrant: CAG against for IBS; test/treat bile acid diarrhoea separately (chronic diarrhoea).

IBS-C

  • Linaclotide: recommend (CAG); lubiprostone: suggest.
  • Osmotic laxatives (PEG): CAG and ACG suggest against for global IBS symptoms — they improve constipation, not pain or bloating; still reasonable for stool frequency.
  • Prucalopride: against for overall IBS-C symptoms.
  • Constipation with straining or incomplete evacuation → consider dyssynergic defecation (anorectal physiology testing).

Prepared 2026-10-28. Not yet verified — check every number against the sources.

Key references

Suggest a correction irritable bowel syndrome